Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 349

1.

Malignancy grading is no better than conventional histopathological grading in small squamous cell carcinoma of tongue and floor of mouth: retrospective study in 128 patients.

Weijers M, Snow GB, Bezemer PD, van der Waal I.

J Oral Pathol Med. 2009 Apr;38(4):343-7. doi: 10.1111/j.1600-0714.2009.00751.x. Epub 2009 Feb 13.

PMID:
19222711
2.

Prognostic importance of paratracheal lymph node metastases.

Plaat RE, de Bree R, Kuik DJ, van den Brekel MW, van Hattum AH, Snow GB, Leemans CR.

Laryngoscope. 2005 May;115(5):894-8.

PMID:
15867661
3.

Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.

Nieuwenhuis EJ, van der Waal I, Leemans CR, Kummer A, Pijpers R, Castelijns JA, Brakenhoff RH, Snow GB.

Head Neck. 2005 Feb;27(2):150-8.

PMID:
15627261
4.

Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.

Colnot DR, Nieuwenhuis EJ, Kuik DJ, Leemans CR, Dijkstra J, Snow GB, van Dongen GA, Brakenhoff RH.

Clin Cancer Res. 2004 Dec 1;10(23):7827-33.

5.

Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.

van Houten VM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, van den Brekel MW, Snow GB, Brakenhoff RH.

Clin Cancer Res. 2004 Jun 1;10(11):3614-20.

6.

The status of the deep surgical margins in tongue and floor of mouth squamous cell carcinoma and risk of local recurrence; an analysis of 68 patients.

Weijers M, Snow GB, Bezemer DP, van dr Wal JE, van der Waal I.

Int J Oral Maxillofac Surg. 2004 Mar;33(2):146-9.

PMID:
15050070
7.

Ultra-sonic nebulizers as a potential source of methicillin-resistant Staphylococcus aureus causing an outbreak in a university tertiary care hospital.

Schultsz C, Meester HH, Kranenburg AM, Savelkoul PH, Boeijen-Donkers LE, Kaiser AM, de Bree R, Snow GB, Vandenbroucke-Grauls CJ.

J Hosp Infect. 2003 Dec;55(4):269-75.

PMID:
14629970
8.

Radioimmunodiagnosis of lymph node metastases in head and neck cancer.

de Bree R, Roos JC, Verel I, van Dongen GA, Snow GB.

Oral Dis. 2003 Sep;9(5):241-8.

PMID:
14628891
9.

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck.

Colnot DR, Roos JC, de Bree R, Wilhelm AJ, Kummer JA, Hanft G, Heider KH, Stehle G, Snow GB, van Dongen GA.

Cancer Immunol Immunother. 2003 Sep;52(9):576-82.

PMID:
14627130
10.

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA.

J Nucl Med. 2003 Oct;44(10):1663-70.

11.

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.

Börjesson PK, Postema EJ, Roos JC, Colnot DR, Marres HA, van Schie MH, Stehle G, de Bree R, Snow GB, Oyen WJ, van Dongen GA.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3961S-72S.

12.

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

Verel I, Visser GW, Boerman OC, van Eerd JE, Finn R, Boellaard R, Vosjan MJ, Stigter-van Walsum M, Snow GB, van Dongen GA.

Cancer Biother Radiopharm. 2003 Aug;18(4):655-61.

PMID:
14503961
13.
14.

Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction.

Nieuwenhuis EJ, Leemans CR, Kummer JA, Denkers F, Snow GB, Brakenhoff RH.

Lab Invest. 2003 Aug;83(8):1233-40. Erratum in: Lab Invest. 2003 Dec;83(12):1917. Kummer, Alain [corrected to Kummer, J Alain].

PMID:
12920252
15.

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Verel I, Visser GW, Boellaard R, Stigter-van Walsum M, Snow GB, van Dongen GA.

J Nucl Med. 2003 Aug;44(8):1271-81.

16.

Lymphoscintigraphic details of sentinel lymph node detection in 82 patients with squamous cell carcinoma of the oral cavity and oropharynx.

Nieuwenhuis EJ, Pijpers R, Castelijns JA, Snow GB.

Nucl Med Commun. 2003 Jun;24(6):651-6.

PMID:
12766600
17.

Basic principles, applications in oncology and improved selectivity of photodynamic therapy.

Vrouenraets MB, Visser GW, Snow GB, van Dongen GA.

Anticancer Res. 2003 Jan-Feb;23(1B):505-22. Review.

PMID:
12680139
18.

Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.

Nieuwenhuis EJ, Jaspars LH, Castelijns JA, Bakker B, Wishaupt RG, Denkers F, Leemans CR, Snow GB, Brakenhoff RH.

Clin Cancer Res. 2003 Feb;9(2):755-61.

19.

Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma.

de Nooij-van Dalen AG, van Dongen GA, Smeets SJ, Nieuwenhuis EJ, Stigter-van Walsum M, Snow GB, Brakenhoff RH.

Int J Cancer. 2003 Mar 1;103(6):768-74.

20.

Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.

van Houten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, Leemans R, van der Waal I, Snow GB, Brakenhoff RH.

J Pathol. 2002 Dec;198(4):476-86.

PMID:
12434417
21.

Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study.

Colnot DR, Ossenkoppele GJ, Roos JC, Quak JJ, de Bree R, Börjesson PK, Huijgens PC, Snow GB, van Dongen GA.

Clin Cancer Res. 2002 Nov;8(11):3401-6.

22.

Assessment of patency of the internal jugular vein following neck dissection and microvascular flap reconstruction by power Doppler ultrasound.

de Bree R, van den Berg FG, van Schaik C, Beerens AJ, Manoliu RA, Castelijns JA, Snow GB, Leemans CR.

J Laryngol Otol. 2002 Aug;116(8):622-6.

PMID:
12389691
23.

Multiple head and neck tumors frequently originate from a single preneoplastic lesion.

Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Van Der Wal JE, Snow GB, Leemans CR, Braakhuis BJ.

Am J Pathol. 2002 Sep;161(3):1051-60.

24.

Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up.

van der Wal JE, Becking AG, Snow GB, van der Waal I.

Head Neck. 2002 Aug;24(8):779-83.

PMID:
12203804
25.

Nonmalignant oral keratinocytes from patients with head and neck squamous cell carcinoma show enhanced metabolism of retinoic acid.

Klaassen I, Cloos J, Smeets SJ, Brakenhoff RH, Tabor MP, Snow GB, Braakhuis BJ.

Oncology. 2002;63(1):56-63.

PMID:
12187072
26.

Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts.

Verel I, Heider KH, Siegmund M, Ostermann E, Patzelt E, Sproll M, Snow GB, Adolf GR, van Dongen GA.

Int J Cancer. 2002 May 20;99(3):396-402.

27.
28.

The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients.

Weijers M, Snow GB, Bezemer PD, van der Wal JE, van der Waal I.

J Oral Pathol Med. 2002 Jan;31(1):11-5.

PMID:
11896817
29.

Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node?

Nieuwenhuis EJ, Castelijns JA, Pijpers R, van den Brekel MW, Brakenhoff RH, van der Waal I, Snow GB, Leemans CR.

Head Neck. 2002 Mar;24(3):282-9.

PMID:
11891961
30.

Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions.

Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH.

Head Neck. 2002 Feb;24(2):198-206. Review.

PMID:
11891950
31.

Botulinum toxin A in the treatment of patients with Frey syndrome.

Beerens AJ, Snow GB.

Br J Surg. 2002 Jan;89(1):116-9.

PMID:
11851676
32.

Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene.

Tabor MP, van Houten VM, Kummer JA, Vosjan MJ, Vlasblom R, Snow GB, Leemans CR, Braakhuis BJ, Brakenhoff RH.

Genes Chromosomes Cancer. 2002 Feb;33(2):168-77.

PMID:
11793443
33.

The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up.

van Agthoven M, van Ineveld BM, de Boer MF, Leemans CR, Knegt PP, Snow GB, Uyl-de Groot CA.

Eur J Cancer. 2001 Nov;37(17):2204-11.

PMID:
11677108
34.

Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy.

Colnot DR, Wilhelm AJ, Cloos J, Roos JC, de Bree R, Quak JJ, Snow GB, van Dongen GA.

J Nucl Med. 2001 Sep;42(9):1364-7.

35.

Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells.

Klaassen I, Brakenhoff RH, Smeets SJ, Snow GB, Braakhuis BJ.

Br J Cancer. 2001 Aug 17;85(4):630-5.

36.

Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.

van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH.

Int J Cancer. 2001 Jul 15;93(2):232-5.

37.

Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.

Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijders PJ, Snow GB, Leemans CR, Braakhuis BJ.

Clin Cancer Res. 2001 Jun;7(6):1523-32.

38.

Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience.

Colnot DR, Quak JJ, Roos JC, de Bree R, Wilhelm AJ, Snow GB, van Dongen GA.

Head Neck. 2001 Jul;23(7):559-65.

PMID:
11400244
39.
40.
41.

Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.

Vrouenraets MB, Visser GW, Stigter M, Oppelaar H, Snow GB, van Dongen GA.

Cancer Res. 2001 Mar 1;61(5):1970-5.

42.

Intracranial metastases in patients with squamous cell carcinoma of the head and neck.

de Bree R, Mehta DM, Snow GB, Quak JJ.

Otolaryngol Head Neck Surg. 2001 Feb;124(2):217-21.

PMID:
11226960
43.

Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients.

van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blomberg-van der Flier BM, Kuik DJ, Langendoen SI, Snow GB, Green CJ, van Leeuwen PA.

Am J Clin Nutr. 2001 Feb;73(2):323-32.

PMID:
11157331
44.

Head and neck squamous cell carcinoma: US-guided fine-needle aspiration of sentinel lymph nodes for improved staging--initial experience.

Colnot DR, Nieuwenhuis EJ, van den Brekel MW, Pijpers R, Brakenhoff RH, Snow GB, Castelijns JA.

Radiology. 2001 Jan;218(1):289-93.

PMID:
11152817
45.

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.

Colnot DR, Quak JJ, Roos JC, van Lingen A, Wilhelm AJ, van Kamp GJ, Huijgens PC, Snow GB, van Dongen GA.

J Nucl Med. 2000 Dec;41(12):1999-2010.

46.

Survival of malnourished head and neck cancer patients can be predicted by human leukocyte antigen-DR expression and interleukin-6/tumor necrosis factor-alpha response of the monocyte.

van Bokhorst-de van der Schuer, von Blomberg-van der Flier BM, Kuik DJ, Scholten PE, Siroen MP, Snow GB, Quak JJ, van Leeuwen PA.

JPEN J Parenter Enteral Nutr. 2000 Nov-Dec;24(6):329-36.

PMID:
11071592
47.

Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.

van Houten VM, Tabor MP, van den Brekel MW, Denkers F, Wishaupt RG, Kummer JA, Snow GB, Brakenhoff RH.

Clin Cancer Res. 2000 Oct;6(10):3803-16. Review.

48.

Advanced squamous cell carcinoma of the base of the tongue treated with surgery and post-operative radiotherapy.

Tiwari RM, van Ardenne A, Leemans CR, Quak JJ, Tobi H, Mehta DM, Snow GB.

Eur J Surg Oncol. 2000 Sep;26(6):556-60.

PMID:
11034805
49.

Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.

Vrouenraets MB, Visser GW, Loup C, Meunier B, Stigter M, Oppelaar H, Stewart FA, Snow GB, van Dongen GA.

Int J Cancer. 2000 Oct 1;88(1):108-14.

50.

Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.

Stroomer JW, Roos JC, Sproll M, Quak JJ, Heider KH, Wilhelm BJ, Castelijns JA, Meyer R, Kwakkelstein MO, Snow GB, Adolf GR, van Dongen GA.

Clin Cancer Res. 2000 Aug;6(8):3046-55.

Supplemental Content

Support Center